Chimeric Therapeutics Limited (ASX:CHM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0020
0.00 (0.00%)
Mar 4, 2026, 3:56 PM AEST

Chimeric Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
2.55.763.052.3618.3822.41
Cash & Short-Term Investments
2.55.763.052.3618.3822.41
Cash Growth
-50.60%88.58%29.22%-87.15%-17.98%22410099.00%
Accounts Receivable
2.534.550.096.660.04-
Other Receivables
----2.620.02
Receivables
2.534.550.096.662.660.02
Other Current Assets
0.090.220.080.330.130.23
Total Current Assets
5.1310.533.229.3521.1722.67
Property, Plant & Equipment
--00.010.020.01
Long-Term Investments
--0.040.040.04-
Other Intangible Assets
0.811.0412.0112.9813.6513.83
Total Assets
5.9321.5715.2722.3834.8836.5
Accounts Payable
6.56.573.27.414.72.04
Accrued Expenses
0.181.753.243.771.831.06
Other Current Liabilities
0.716.33.663.522.494.26
Total Current Liabilities
7.3814.6110.114.699.027.35
Pension & Post-Retirement Benefits
00----
Other Long-Term Liabilities
1.574.982.712.020.154.02
Total Liabilities
8.9619.612.816.719.1711.37
Common Stock
77.4870.1663.5153.9351.8137.37
Retained Earnings
-87.55-76.33-66.56-56.78-30.86-15.18
Comprehensive Income & Other
7.048.155.528.514.762.94
Shareholders' Equity
-3.031.972.475.6625.7125.13
Total Liabilities & Equity
5.9321.5715.2722.3834.8836.5
Net Cash (Debt)
2.55.763.052.3618.3822.41
Net Cash Growth
-50.60%88.58%29.22%-87.15%-17.98%-
Net Cash Per Share
0.000.000.000.010.050.12
Filing Date Shares Outstanding
3,2993,255905.15529.4425.28330.86
Total Common Shares Outstanding
3,2992,015876.06506.69425.28330.86
Working Capital
-2.26-4.09-6.87-5.3412.1515.31
Book Value Per Share
-0.000.000.000.010.060.08
Tangible Book Value
-3.83-9.07-9.54-7.3212.0511.3
Tangible Book Value Per Share
-0.00-0.00-0.01-0.010.030.03
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.